NEWS
News Articles
Research startup develops new stroke patient therapies
ArunA Bio continues impactful research through UGA and Athens partnerships For husband-and-wife duo Steve Stice and Tracey Worthington Stice, supporting Athens means supporting the health of the community’s residents as well as its economy. Steve, director of the Regenerative Bioscience Center at the University of Georgia, and Tracey are the co-founders of ArunA Bio, a research startup currently developing…
Read MoreABBOTT RECEIVES FDA EUA FOR LABORATORY PCR ASSAY THAT DETECTS AND DIFFERENTIATES SARS-COV-2, FLU A, FLU B AND RSV IN ONE TEST – AND FDA EUA FOR ASYMPTOMATIC USAGE OF ALINITY M COVID-19 TEST
— Abbott’s Alinity™ m Resp-4-Plex assay will allow healthcare workers to test for four viruses in one test, a critically important tool as flu presents with similar symptoms— The test helps save on much-needed testing supplies since it allows for testing for all four viruses with one swab— Assay will run on Abbott’s most advanced…
Read MoreGeoVax Expands and Strengthens Intellectual Property Portfolio
Filings Made in Corporate Focus Areas of SARS-CoV-2 and Immuno-Oncology Atlanta, GA, March 4, 2021 – GeoVax Labs, Inc. (NasdaqCM: GOVX) (“GeoVax” or the “Company”), a biotechnology company developing human immunotherapies and vaccines against infectious diseases and cancer, today announced the filing of two additional patent applications important to the Company’s key focus on vaccines against SARS-CoV-2…
Read MoreGeorgia Bio Names 2021 Golden Helix Award Winners
Georgia Department of Economic Development’s EJane Caraway and Georgia Research Alliance’s Susan Shows to be Honored ATLANTA, GA (March 3, 2021) – Georgia Bio, the state’s life science trade association, will virtually celebrate its annual Golden Helix Awards on Thursday, April 1st. Georgia Bio is pleased to announce the winners of the 2021 Golden Helix Awards. …
Read MoreBiden to announce ‘historic partnership’: Merck will help make Johnson & Johnson coronavirus vaccine, officials say
The administration brokered the arrangement amid concerns about Johnson & Johnson’s production delays President Biden will announce Tuesday that pharmaceutical giant Merck will help make Johnson & Johnson’s single-shot coronavirus vaccine — an unusual pact between fierce competitors that could sharply boost the supply of the newly authorized vaccine, according to senior administration officials. The officials, who spoke…
Read MoreCovid-19 Vaccines Yield Breakthroughs in Long-Term Fight Against Infectious Disease
Researchers in gene-based technology produced a class of vaccines they believe can protect against all manner of outbreaks in the years to come The pandemic has opened a new era for vaccines developed with gene-based technologies, techniques that have long stumped scientists and pharmaceutical companies, suggesting the possibility of future protection against a range of infectious disease.…
Read More